Abstract Overview: Perioperative Chemotherapy for Resectable Pancreatic Cancer - 102164

Spotlight
Video

Abstract Overview: Perioperative Chemotherapy for Resectable Pancreatic Cancer

Loading........
Description: Davendra Sohal, MD of Cleveland Clinic gives an overview of his presentation, Perioperative mFOLFIRINOX vs. Gemcitabine/nab-Paclitaxel as Therapy for Resectable Pancreatic Adenocarcinoma, which was discussed at the 2017 ASCO Annual Meeting in Chicago, IL.

TPS4152: Perioperative mFOLFIRINOX vs. Gemcitabine/nab-Paclitaxel as Therapy for Resectable Pancreatic Adenocarcinoma
Shared By : AnnualMeeting2017
Posted on : 06/05/17
Added : 9 months ago
Category : Pancreatic Cancer



Recommended

Nothing found.

More From AnnualMeeting2017

Nothing found.